The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Forecasted Market Value Of The Connected Drug Delivery Devices Market Across 2026–2030?
The connected drug delivery devices market size has experienced significant expansion in recent years. It is projected to increase from $9.27 billion in 2025 to $11.48 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 23.8%. Historically, this growth can be attributed to the rising adoption of chronic disease management devices, the increasing prevalence of diabetes and respiratory disorders, technological innovations in smart syringes and inhalers, growing healthcare digitization initiatives, and enhanced awareness regarding medication adherence.
The connected drug delivery devices market size is projected to experience substantial growth in the forthcoming years, achieving a valuation of $27.02 billion by 2030, at a compound annual growth rate (CAGR) of 23.9%. This expansion during the forecast period is primarily fueled by the increasing need for remote patient observation, the broadening scope of connected healthcare ecosystems, the integration of AI-based predictive analytics, the rise of wearable drug delivery devices, and encouraging government policies for digital health adoption. Noteworthy trends anticipated in this period encompass personalized medication adherence tracking, remote patient monitoring solutions, integration with electronic health records (EHR), data-driven dose optimization, and the provision of real-time alerts and notifications.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13962&type=smp
What Major Growth Drivers Are Shaping The Outlook Of The Connected Drug Delivery Devices Market?
The growing significance of remote patient monitoring is projected to boost the expansion of the connected drug delivery device market in the coming years. Remote patient monitoring represents a healthcare delivery strategy that employs technology to remotely track patient health and medical data. Connected drug delivery devices enhance this monitoring by enabling precise tracking of medication use and adherence, facilitating prompt interventions, and supporting individualized care management. For example, in May 2024, the Journal of Medical Internet Research, a Canada-based peer-reviewed journal, reported that 38.78% of US adults had utilized telehealth services in the past year. Thus, the increasing importance of remote patient monitoring is propelling the growth of the connected drug delivery device market.
What Segmentation Levels Are Considered In The Connected Drug Delivery Devices Market?
The connected drug delivery devices market covered in this report is segmented –
1) By Type: Standalone Components And Software, Integrated Devices
2) By Technology: Bluetooth, Near-Field Communication (NFC), Other Technologies
3) By Administration: Parenteral, Inhalational
4) By Application: Asthma, Chronic Obstructive Pulmonary Disease, Diabetes Management, Other Applications
Subsegments:
1) By Standalone Components And Software: Mobile Applications, Connectivity Modules, Data Analytics Software
2) By Integrated Devices: Smart Inhalers, Smart Auto-injectors, Connected Syringes, Wearable Drug Delivery Devices
What Trends Are Projected To Affect The Connected Drug Delivery Devices Market?
Leading companies in the connected drug delivery devices market are prioritizing the introduction of advanced, longer-lasting, and more integrated digital health solutions to enhance treatment ease, refine monitoring precision, and ensure uninterrupted connection with automated therapy systems. For instance, in November 2025, Dexcom, a US-based healthcare company, is set to launch its new G7 15 Day continuous glucose monitor in the U.S. on December 1, 2025, for adults with diabetes. This device, having recently received FDA clearance, will become the longest-wearing CGM available, offering up to 15.5 days of use with an improved accuracy MARD of 8%. Upon its release, it will be accessible through DME providers and covered for Medicare users. The updated sensor integrates with the iLet Bionic Pancreas, Omnipod 5, and soon Tandem pumps, and also supports Dexcom’s new Smart Basal insulin optimization system. With less frequent sensor changes, a waterproof design, smartwatch connectivity, and simplified logging features, the G7 15 Day aims to deliver greater convenience and superior long-term glucose management.
Which Leading Firms Are Contributing To The Growth Of The Connected Drug Delivery Devices Market?
Major companies operating in the connected drug delivery devices market are Pfizer Inc., Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Eli Lilly and Company, Novo Nordisk A/S, Becton Dickinson and Company, Phillips-Medisize Corporation, AptarGroup Inc., Dexcom Inc., West Pharmaceutical Services Inc., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed AG, Meridian Medical Technologies LLC, Propeller Health, Findair Sp. z.o.o, Omron Healthcare Co. Ltd, Omnicell Inc., BD Medical
Read the full connected drug delivery devices market report here:
Which Regions Are Projected To Dominate The Connected Drug Delivery Devices Market In The Coming Years?
North America was the largest region in the connected drug delivery market in 2025. The regions covered in the connected drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Connected Drug Delivery Devices Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=13962&type=smp
Browse Through More Reports Similar to the Global Connected Drug Delivery Devices Market 2026, By The Business Research Company
Connected Drug Delivery Devices Market Report 2026
Drug Delivery Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Drug Delivery Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model